Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Phase I Reactions: Reductive Reactions

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...

Drug Biotransformation: Overview

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying critical period of type 2 diabetes in Chinese population with leading molecules based on dynamic network biomarkers.

Scientific reports·2026

Same author

Towards the construction of a virtual yeast.

Nature·2026

Same author

Disruption of dynactin complex function in intellectual disability.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Efficient preservation of old methane-derived organic carbon in deep-sea surface sediments.

Nature communications·2026

Same author

CauFinder: Steering Cell-State and Phenotype Transitions by Causal Disentanglement Learning.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

stMixer for Scalable Mosaic Integration and Label Transfer in Spatial Histology and Multi-Omics.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Search research articles

Related Experiment Video

Updated: May 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Drug repositioning framework by incorporating functional information.

Zikai Wu, Yong Wang, Luonan Chen

IET Systems Biology

|September 27, 2013

Summary

This summary is machine-generated.

This study introduces a computational framework for drug repositioning, enhancing efficiency by integrating gene expression and functional data. The approach identifies potential new uses for existing drugs, offering insights into drug mechanisms.

More Related Videos

Mapping Dysfunctional Protein-Protein Interactions in Disease

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

Related Experiment Videos

Last Updated: May 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Mapping Dysfunctional Protein-Protein Interactions in Disease

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

Area of Science:

Systems biology
Computational biology
Drug discovery

Background:

Drug repositioning is a cost-effective strategy to identify new therapeutic uses for existing drugs.
High-throughput data and computational methods are increasingly important in drug repositioning.
Current methods may lack comprehensive biological interpretation.

Purpose of the Study:

To develop a general computational framework for drug repositioning by integrating diverse functional information.
To improve the efficiency and biological rationale of identifying new drug indications.
To provide insights into drug action mechanisms through functional analysis.

Main Methods:

Identification of differentially expressed gene sets in disease states and under drug treatment.
Association of diseases and drugs based on the overlap of gene sets, evaluated through biological function.
Two strategies for assessing functional overlap: using gene lethality and analyzing biological process perturbation profiles via pathways and Gene Ontology (GO) terms.

Main Results:

The proposed framework successfully identified potential drug repositioning candidates.
Preliminary results on prostate cancer demonstrated improved drug repositioning efficiency.
Integration of various functional information sources proved complementary and enhanced biological interpretation.

Conclusions:

The developed framework offers a robust approach to drug repositioning by incorporating multi-faceted functional data.
This method enhances the biological understanding and rationale behind drug repositioning strategies.
The framework provides valuable insights into the mechanisms of drug action.